Integration and creativity are at the core of our healthcare approach. Aided by our consumer driven insight, derived from our experience outside healthcare, we add an extra dimension in a regulated ...

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a global scale. We also syndicate our video library in ...

GSK’s new drug application for its investigational oral antibiotic gepotidacin has been accepted for priority review by the ...

Stirred has announced that it has been awarded a Platinum Medal from EcoVadis, placing it in the top 1% of companies globally ...

Few organisations will get it that wrong, but the pharmaceutical launch pad is scorched with failure and the debris from ...

LONDON–(BUSINESS WIRE)–The Women’s Brain Foundation (WBF), the global pioneer that has advanced the inclusion of sex- and gender-based evidence-generation in all research, drug development, and ...

Amgen has shared positive top-line results from a late-stage trial of its B cell-depleting therapy Uplizna (inebilizumab-cdon ...

Boehringer Ingelheim’s Ulrike Graefe-Mody on her career path; Driving launch excellence; Top trends coming out of ESMO 2024 ...

Johnson & Johnson’s (J&J) investigational FcRn blocker nipocalimab has demonstrated sustained disease control in adolescents with the rare autoimmune disease generalised myasthenia gravis (gMG), ...

• Mtech Access – Powered by Petauri™ are excited to be returning to ISPOR Europe this November. The team will be joined by colleagues from across Petauri, including Delta Hat • Mtech Access and ...

Pfizer has announced positive overall survival (OS) results from a late-stage study of its prostate cancer combination treatment. The phase 3 TALAPRO-2 trial has been evaluating the drugmaker’s PARP ...

Johnson & Johnson’s (J&J) Tecvayli (teclistamab) has been recommended by the National Institute for Health and Care Excellence (NICE) to treat relapsed and refractory multiple myeloma (RRMM) in adults ...